a few people working at a table

Press Releases

Ladenburg Thalmann Acts as Sole Book-Running Manager for Ra Medical Systems, Inc. (RMED) in its $12.1 Million Follow-On Offering

Transaction Information Ra Medical Systems, Inc. (NYSE American: RMED) announced the closing of an underwritten...

Ladenburg Thalmann Acts as Exclusive Placement Agent for NovaBay Pharmaceuticals (NBY) in its $15.0 Million Private Placement

Transaction Information NovaBay Pharmaceuticals, Inc. (NBY) announced it has entered into a Securities Purchase...

Ladenburg Thalmann Acts as Lead Manager for Evaxion Biotech in its $27.6 Million Follow-On Offering

Transaction Information Evaxion Biotech A/S (NASDAQ: EVAX), announced the closing of its follow-on public...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Helius Medical Technologies, Inc. (HSDT) in its $11.1 Million Follow-On Offering

Transaction Information Helius Medical Technologies, Inc. (Nasdaq: HSDT) (TSX: HSM) announced underwritten...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Nuwellis, Inc. (NUWE) in its $10.0 Million Follow-On Offering

Transaction Information Nuwellis, Inc. (NASDAQ: NUWE), announced the closing of its previously announced...

Ladenburg Thalmann Acts as Exclusive Placement Agent for Hancock Jaffe Laboratories (HJLI) in its $20 Million Registered Direct Offering Priced At-the-Market

Transaction Information Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) announced it has entered into a...

Ladenburg Thalmann Acts as Co-Manager for Onconova Therapeutics, Inc. (ONTX) in its $21.0 Million Follow-On Offering

Transaction Information Onconova Therapeutics, Inc. (NASDAQ: ONTX), announced the closing of its...

Ladenburg Thalmann Acts as Exclusive Financial Advisor to Spero Therapeutics, Inc. (Nasdaq: SPRO) in its $125 Million Revenue Interest Financing

Transaction Information Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical...

Ladenburg Thalmann acts as Lead Bookrunner for NewLake Capital Partners Inc. on its Initial Public Offering of $101.6 million

Transaction Information New Canaan, CT - NewLake Capital Partners, Inc. (OTCQX:NLCP) (the "Company"), a leading...